On December 29, 2022, with the signing of the Consolidated Appropriations Act of 2023 (the Act), Congress eliminated the DATA-Waiver Program. This effects all Drug Enforcement Agency (DEA) registrants. For detailed information on how the Act affects West Virginia Medicaid providers, please see the below memo.
Removal of the DEA-DATA-Waiver Requirement for Buprenorphine Memorandum
For more information, please contact the Bureau for Medical Services (BMS) at 304-558-1700.